SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Auxly Cannabis Group Inc. CBWTF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Auxly Cannabis Group Inc. (CBWTF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.10. It has a SharesGrow Score of 58/100, indicating a above average investment profile with 3 out of 7 criteria passed.

Financials: revenue is $151M, +17.2%/yr average growth. Net income is $42M, growing at +161.6%/yr. Net profit margin is 27.6% (strong). Gross margin is 16.3% (-2.7 pp trend).

Balance sheet: total debt is $58M against $177M equity (Debt-to-Equity (D/E) ratio 0.32, conservative). Current ratio is 2.2 (strong liquidity). Debt-to-assets is 21.2%. Total assets: $271M.

Analyst outlook: 0 / 1 analysts rate CBWTF as buy (0%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 90/100 (Pass), Past 25/100 (Fail), Health 67/100 (Partial), Moat 21/100 (Fail), Future 20/100 (Fail), Income 85/100 (Pass).

CBWTF SharesGrow Score Overview

58/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 90/100

Financials — average growth

PAST 25/100

strong — trend

HEALTH 67/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 21/100

Gross margin is + market cap

FUTURE 20/100

Analyst outlook — as buy

INCOME 85/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CBWTF

CBWTF trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

CBWTF: +17.2%/yr revenue is, +161.6%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

CBWTF: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet CBWTF: Debt-to-Equity (D/E) ratio 0.32 (conservative), Current ratio is 2.2 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

CBWTF: Gross margin is 16.3% (-2.7 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 21/100. ≥ 70 = Pass.

View details →

Analyst outlook: 0 / 1 analysts rate CBWTF as buy (0%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

CBWTF: Net profit margin is 27.6%. healthy (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range0.044-0.136

Volume216.06K

Avg Volume (30D)753.02K

Market Cap$135.4M

Beta (1Y)1.11

Share Statistics

EPS (TTM)0.03

Shares Outstanding$1.33B

IPO Date2017-04-07

Employees388

CEOHugo Alves

Financial Highlights & Ratios

Revenue (TTM)$151.36M

Gross Profit$24.62M

EBITDA$-12.97M

Net Income$41.82M

Operating Income$-24.41M

Total Cash$32.64M

Total Debt$57.6M

Net Debt$25.1M

Total Assets$271.41M

Price / Earnings (P/E)3.1

Price / Sales (P/S)0.89

Analyst Forecast

Rating ConsensusHold

Analysts Covering1

Buy 0% Hold 100% Sell 0%

Company Info

CountryCA

ExchangeOther OTC

CurrencyUSD

ISINCA05335P1099

Price Chart

CBWTF

Auxly Cannabis Group Inc. ↗ · Other OTC

Healthcare • Drug Manufacturers - Specialty & Generic

0.04 52WK RANGE 0.14

People Also View

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

TerrAscend Corp.

Columbia Care Inc.

Cipher Pharmaceuticals Inc.

Creso Pharma Limited

Willow Biosciences Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message